AcelleRX Therapeutics aims to help people who suffer a myocardial infarction (MI) or chronic heart failure (HF) via a gene or protein capable of recruiting stem cells to help repair the heart. If the science can be successfully commercialized, this spin-out from the Cleveland Clinic in Ohio could have a big impact on a big slice of the market.
10265 Carnegie Avenue
Cleveland, OH 44106
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
